Stockreport

LEVI & KORSINSKY, LLP: VISTAGEN THERAPEUTICS STOCK DROPS OVER 80% FOLLOWING CLINICAL TRIAL DISCLOSURE -- CLASS ACTION SEEKS DAMAGES FOR INVESTORS

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com